Literature DB >> 36057019

Cystectomy for Benign Indications.

Owen P Aftreth1, Christopher F Tenggardjaja1, Polina Reyblat2.   

Abstract

PURPOSE OF REVIEW: This article evaluates the historical influences, current use, surgical techniques, and recent evidence on outcomes for cystectomy performed for benign indications. RECENT
FINDINGS: At the population level, cystectomy for benign indications has similar perioperative morbidity to radical cystectomy for cancer. Postoperative patient satisfaction is high and functional outcomes appear good, including sexual function. Patient regret about diversion choice is low provided decisions are well informed. Cystectomy is important both as a primary procedure for benign disease and as an adjunct to primary urinary diversion. Early morbidity remains high but long-term results are encouraging. Further studies are needed to guide patient decision-making, to help inform diversion choice, and to understand the long-term impact of surgery and diversion choice on quality of life.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cystectomy; Interstitial cystitis; Neurogenic bladder; Radiation cystitis; Urinary diversion; Urogenital fistula

Mesh:

Year:  2022        PMID: 36057019     DOI: 10.1007/s11934-022-01100-1

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  3 in total

1.  Canadian Urological Association guideline: Diagnosis, management, and surveillance of neurogenic lower urinary tract dysfunction - Full text.

Authors:  Alex Kavanagh; Richard Baverstock; Lysanne Campeau; Kevin Carlson; Ashley Cox; Duane Hickling; Genviève Nadeau; Lynn Stothers; Blayne Welk
Journal:  Can Urol Assoc J       Date:  2019-06       Impact factor: 1.862

Review 2.  The role of cystectomy for non-malignant bladder conditions: a review.

Authors:  Julio T Chong; MaryEllen T Dolat; Adam P Klausner; Ema Dragoescu; Lance J Hampton
Journal:  Can J Urol       Date:  2014-10       Impact factor: 1.344

3.  Cystectomy for benign disease: readmission, morbidity, and complications.

Authors:  Scott G Erpelding; Adam Dugan; Sudhir Isharwal; Stephen Strup; Andrew James; Shubham Gupta
Journal:  Can J Urol       Date:  2018-10       Impact factor: 1.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.